Fosun Pharmaceutical, which is based out of China, is planning to make a bid on Stada, a German generic drug company. Stada is currently in the middle of a takeover fight between two private equity consortia, at a price tag of about $3.8 billion. Fosun Pharma is looking to expand outside of the domestic market. Last year, it made an acquisition in India, picking up Gland Pharma. Fosun is expected to continue to be active in mergers and acquisitions in the near future.